TKI
New Indication Granted for Bosutinib to Treat Newly Diagnosed Ph+ CML
Bosulif is now indicated for adults with newly diagnosed chronic phase, Philadelphia chromosome–positive ...
DECEMBER 30, 2017
Strategies for Stopping TKIs in CML Growing Clearer
San Diego—In patients with CML, longer treatment duration is associated with an increase in the odds ratio ...
MARCH 14, 2017
PD Expression May Predict TKI-Related Outcomes of mRCC
Patients mRCC that expresses programmed death cells experience poorer overall and progression-free survival with ...
FEBRUARY 15, 2017
Load more